# Attention - Publication of AllerPops Clinical Trial | AllerPops

- Canonical URL: https://wefunder.com/feed/165194
- Entity ID: wefunder:feed_item:165194
- Published at: 2023-06-28 18:06:49 UTC
- Updated at: 2025-07-09 03:23:35 UTC

## Author
Cliff Han

## Subject
AllerPops

## Content
Hello Everyone,I have a very exciting announcement to make!In the last few months, we have completed the analysis of our clinical trial data, including the oral microbiome data of saliva samples collected from the trial and set a path for IP protection of our new discovery. We are now ready to publish the trial results and let the world know our progress to end the allergy epidemic.  This has been a tremendous initiative and I'm so excited to share it with all of our supporters. This is the moment we've been working toward since I launched AllerPops and is the final step required to get on store shelves around the country.This is where we're at now: Register our clinical trial in clinicaltrials.gov. This is a requirement for most peer-reviewed journal to publish results from a clinical trial. We have submitted the registration and wait for their review and approval for public release of the trial. This will take a couple of weeks.Preprint release. We have drafted the manuscript on AllerPops clinical trial that is ready to submit to a preprint deposit database, https://www.medrxiv.org/ when the above registration is complete. The preprint is available for public to comment. We’ll let you know when it is released. Peer-reviewed publication. We will submit the manuscript to a selected journal after the registration at clinicaltrials.gov. The peer-reviewed process takes on average 5 months.Important! This funding round will be closing soon, please be sure to lock in your investment. This will be the last opportunity to invest at our current valuation.Thank you for your continued support and belief in our vision. Together, we are poised to revolutionize the field of allergy treatment and make a lasting impact on the lives of millions. We appreciate your trust and are grateful for the opportunity to bring this groundbreaking solution to the market.CliffClick here to Invest in AllerPops